The SAGES scoring model leads to personalized treatment via the combination of TACE, TKIs and ICIs for unresectable hepatocellular carcinoma

Background and aimsTranscatheter chemoembolization (TACE) combined with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) shows promising efficacy in treating unresectable hepatocellular carcinoma (uHCC), but the specific patient population that would benefit most from this r...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hesheng Lin, Xueyao Wang, Jianhong Zhong, Ning Peng, Shaoping Liu, Fanjian Zeng, Wenfeng Li, Ze Su, Junjie Ou, Peisheng Wu, Hongbing Yao, Shuqun Li
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-04-01
Edice:	Frontiers in Immunology
Témata:	immune checkpoint inhibitor overall survival progression-free survival sages score transarterial chemoembolization tyrosine kinase inhibitor
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1802427/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!